Abstract
ImuVert, a new biological response modifier, was evaluated for toxicity and potential efficacy in patients with advanced cancer. This agent consists of sized, labile, natural membrane vesicles associated with ribosomes derived fromSerratia marcescens. ImuVert induces enhanced in vitro macrophage and natural-killer-cell-mediated cytotoxicity, and has demonstrated antitumor activity in palpable animal tumor systems. A group of 39 patients with a variety of tumors, 25 men, 14 women, with a mean performance status (Karnofsky) of 80% and median age of 57 years were entered into this trial. ImuVert was administered subcutaneously weekly for a minimum of 3 weeks. A total of 183 treatments were evaluated. Flu-like systemic toxicities, including fever, chills, nausea, vomiting, diarrhea and hypotension were observed. Erythema, induration and tenderness developed at the injection sites. Myelosuppression, thrombocytopenia, anaphylaxis, rental and hepatic toxicities did not occur. All symptoms resolved within 24 h. Two patients with nodular lymphoma achieved a partial response and two minor responses were seen in patients with glioblastoma and melanoma. On the basis of ImuVert's biological activity, and tolerable toxicity it warrants further clinical investigation.
Key words: Biological response modifiers, Natural membrane vesicle, Ribosome, Serratia
References
- 1.Aoki T, Miyakoshi H, Horikawa Y, Usuda Y. Staphage lysate and lertiman as immunomodulators and/or immunopotentiators in clinical and experimental Systems. In: Hersh EM, Chivigos MA, Mastrangelo MJ, editors. Augmenting agents in cancer therapy. New York: Raven; 1981. pp. 101–112. [Google Scholar]
- 2.Ascensao J, Mittelman A, Renichet K, Lin Yao B, Urban R, Feldman E, Arlin Z, Podack E. Activated natural killer (NK) cell activity in patients with advanced cancer treated with ImuVert. Proc Am Assoc Cancer Res. 1987;28:1. [Google Scholar]
- 3.Badalament RA, Herr HW, Wong GY, Pinsky CM, Gnecco C, Fair WR, Oettgen HF. A prospective randomized trial of maintenance versus non-maintenance intravesical bacillus Calmette-Guérin (BCG) therapy of superficial bladder cancer. J Clin Oncol. 1987;5:441–449. doi: 10.1200/JCO.1987.5.3.441. [DOI] [PubMed] [Google Scholar]
- 4.Hanna MG, Peters LC. Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs. Cancer Res. 1981;41:4001–4009. [PubMed] [Google Scholar]
- 5.Hanna MG, Brandhorst JS, Peters LC. Active specific immunotherapy of residual micrometastases. Cancer Immunol Immunother. 1979;7:165. [Google Scholar]
- 6.Herr H, Pinsky C, Badalamert R, Gnecco C, Wong G, Whitmore W, Oettgen H. Randomized trial of maintenance versus no maintenance BCG in superficial bladder cancer (abstract) Proc Am Soc Clin Oncol Annu Meet. 1986;5:102. doi: 10.1200/JCO.1987.5.3.441. [DOI] [PubMed] [Google Scholar]
- 7.Ishida N, Hoshino J (1985). A streptococcal preparation as a potent biologic response modifier. Excerpt a Med Int Congr Ser 011–432
- 8.Mastrangelo MJ, Berd D. Immunology with microbial products. In: Mihich E, editor. Immunological approaches to cancer therapeutics. New York: Wiley Interscience; 1982. pp. 75–105. [Google Scholar]
- 9.Oldham RK. Biological: new horizons in pharmaceutical development. J Biol Response Mod. 1983;2:199. [PubMed] [Google Scholar]
- 10.Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, et al. Observation of the systemic administration of autologous, lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985;1313:1485–1492. doi: 10.1056/NEJM198512053132327. [DOI] [PubMed] [Google Scholar]
- 11.Tuttle RL, Cantrell J. C. parvum — determinants of biologic activity. In: Hersh EM, Chiriges MA, Mastrangelo MJ, editors. Augmenting agents in cancer therapy. New York: Raven; 1981. pp. 53–69. [Google Scholar]
- 12.Warren RP, McCall CA, Urban RW. Augmentation of natural killer cell activity by ImuVert: a biological response modifier derived fromSerratia marcescens . Mol Biother. 1989;1:145–151. [PubMed] [Google Scholar]